British insurer Prudential has divested (sold) a 4.5 percent stake in ICICI Prudential Asset Management for Rs 4,900 crore (approximately $545 million), merely one day prior to the fund house’s highly ...

SEPC Limited’s stock, with a market capitalisation of Rs. 1,694 crores, rose to Rs. 8.98, hitting a high of up to 1.81 percent from its previous closing price of Rs. 8.82. However, the stock over the ...

Vision Infra Equipment Solutions announced on December 10 2025 that it has received a work order worth Rs. 12.69 Crores from the unnamed Indian Company to crush boulders into aggregate, dust and ...

Investing.com -- Valneva SE (NASDAQ:VALN) stock gained 3.7% on Thursday after the specialty vaccine company reported positive final Phase 2 antibody persistence and safety results for its chikungunya ...

Investing.com -- Swiss inflation in the midterm has remained practically unchanged, Swiss National Bank Chairman Martin Schlegel said on Thursday. Schlegel added that he expected the bank’s current 0% ...

Ildong Pharmaceutical shows exceptional momentum with a 149% year to date return and a 145% one year gain. A P/E ratio near 31 is offset by a very low PEG ratio of 0.09, indicating strong value ...

Adjusted profit for the current quarter is seen at $1.64 to $1.68 per share, below analysts’ estimates of $1.72, according to LSEG data cited by Reuters. Revenue for the period is anticipated to rise ...

Adjusted profit for the current quarter is seen at $1.64 to $1.68 per share, below analysts’ estimates of $1.72, according to ...

Investing.com -- Schott Pharma (ETR:1SXP) on Thursday reported fiscal 2025 revenue slightly below expectations and issued 2026 guidance that fell short of analyst forecasts.

Investing.com -- STMicroelectronics (EPA:STMPA) announced on Thursday it has established a €1 billion ($1.2 billion) credit line with the European Investment Bank (EIB).

Investing.com -- Sanofi has received approval for two bleeding disorder treatments in China, expanding its hematology portfolio in the country. The French pharmaceutical company announced Thursday ...

For fiscal year 2025-26, the company expects revenue to rise by a mid-single-digit percentage to approximately €2.3 billion. EBIT and EBITA are forecast to increase, with EBIT margins around 11.0-11.5 ...